Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCH
4376
PUT
Dauch Corp
DCH
$1.5B
| $1.24M | ﹤0.01% |
71,900
-106,000
| -60% | -$1.78M |
|
4377
PUT
Equinor
EQNR
$98.2B
| $1.24M | ﹤0.01% |
73,700
-32,200
| -30% | -$523K |
|
4378
Vident International Equity Strategy
VIDI
$456M
| $1.24M | ﹤0.01% |
56,214
-82,542
| -59% | -$1.77M |
|
|
JNS
4379
PUT
DELISTED
Janus Capital Group Inc
JNS
| $1.24M | ﹤0.01% |
88,400
+25,500
| +41% | +$369K |
|
4380
Weyerhaeuser
WY
$17B
| $1.24M | ﹤0.01% |
38,700
| – | – |
|
4381
CALL
Cerus
CERS
$534M
| $1.24M | ﹤0.01% |
198,800
+16,400
| +9% | +$107K |
|
4382
West Pharmaceutical
WST
$23.7B
| $1.24M | ﹤0.01% |
16,580
-40,052
| -71% | -$3.18M |
|
4383
CALL
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.55M
| $1.24M | ﹤0.01% |
22,800
+4,700
| +26% | +$238K |
|
4384
CALL
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$103M
| $1.23M | ﹤0.01% |
149
+118
| +381% | +$1.36M |
|
4385
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.14B
| $1.23M | ﹤0.01% |
52,823
-5,747
| -10% | -$132K |
|
|
ATCO
4386
CALL
DELISTED
Atlas Corp.
ATCO
| $1.23M | ﹤0.01% |
92,600
-37,900
| -29% | -$547K |
|
4387
Invesco Solar ETF
TAN
$1.26B
| $1.23M | ﹤0.01% |
60,727
-57,586
| -49% | -$1.22M |
|
|
PXMC
4388
DELISTED
POWERSHARES FUNDAMENTAL PURE MID CORE PORTFOLIO
PXMC
| $1.23M | ﹤0.01% |
30,299
+4,220
| +16% | +$172K |
|
4389
PUT
Brookfield Infrastructure Partners
BIP
$17.5B
| $1.23M | ﹤0.01% |
59,640
+28,140
| +89% | +$541K |
|
|
MPT
4390
PUT
Medical Properties Trust
MPT
$2.44B
| $1.23M | ﹤0.01% |
83,300
+53,900
| +183% | +$816K |
|
4391
PUT
AMC Global Media
AMCX
$522M
| $1.23M | ﹤0.01% |
23,700
-22,700
| -49% | -$1.24M |
|
|
CUK
4392
DELISTED
Carnival PLC
CUK
| $1.23M | ﹤0.01% |
25,045
-6,546
| -21% | -$308K |
|
|
BMS
4393
CALL
DELISTED
Bemis
BMS
| $1.23M | ﹤0.01% |
24,100
-2,800
| -10% | -$144K |
|
4394
CALL
Ocular Therapeutix
OCUL
$2.28B
| $1.23M | ﹤0.01% |
178,800
+105,000
| +142% | +$640K |
|
|
SJI
4395
DELISTED
South Jersey Industries, Inc.
SJI
| $1.23M | ﹤0.01% |
+41,524
| New | +$1.27M |
|
4396
Huazhu Hotels Group
HTHT
$14.7B
| $1.23M | ﹤0.01% |
108,800
-23,092
| -18% | -$241K |
|
4397
ProShares Merger ETF
MRGR
$15.9M
| $1.23M | ﹤0.01% |
34,012
+25,020
| +278% | +$905K |
|
4398
Delek Logistics
DKL
$3.17B
| $1.23M | ﹤0.01% |
42,891
+33,891
| +377% | +$918K |
|
4399
CALL
Infosys
INFY
$48.8B
| $1.22M | ﹤0.01% |
155,000
-55,600
| -26% | -$458K |
|
4400
NextEra Energy
NEE
$171B
| $1.22M | ﹤0.01% |
40,000
| – | – |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.